NCT00843271Active, not recruiting
Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA
Endothelial Dysfunction, Biomarkers, and Lung Function (MESA LUNG) (MESA Lung ClinCoordCtr IRB)
Source: ClinicalTrials.gov · Last updated 23 Apr 2026
Brief summary (registry, in English)
The purpose of the MESA Lung Study is to assess the role of endothelial dysfunction and genetic susceptibility to subclinical COPD and emphysema.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 4359 (actual)
- First submitted
- 12 Feb 2009
- Start date
- 1 Oct 2004
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Columbia University
- Diseases
- COPD
- NCT number
- NCT00843271
What you commit to
- Study type: Observational
- Participants enrolled: 4359
- From 1 Oct 2004 to the primary completion date, 31 Jan 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- MESA participants without MESA Exam 3 or 4 measurements.
- MESA participants without FMD measurements in Exam 1.
- MESA participants who have not consented to genetic testing.
Who the study is looking for
- A random sample of MESA participants active at Exam 3 and/or 4.
Age in the registry: 45 years to 84 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.